Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
J. Clin. Oncol 2024 Jan 08;[EPub Ahead of Print], L Moreno, R Weston, C Owens, D Valteau-Couanet, M Gambart, V Castel, CM Zwaan, K Nysom, N Gerber, A Castellano, G Laureys, R Ladenstein, J Rössler, G Makin, D Murphy, B Morland, S Vaidya, E Thebaud, N van Eijkelenburg, DA Tweddle, G Barone, J Tandonnet, N Corradini, P Chastagner, C Paillard, FJ Bautista, S Gallego Melcon, B De Wilde, L Marshall, J Gray, SA Burchill, G Schleiermacher, L Chesler, A Peet, MO Leach, K McHugh, R Hayes, N Jerome, H Caron, J Laidler, N Fenwick, G Holt, V Moroz, P Kearns, S Gates, ADJ Pearson, K WheatleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.